Pages that link to "Q72285455"
Jump to navigation
Jump to search
The following pages link to Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocytic leukemia. Australian Leukaemia Study Group (Q72285455):
Displaying 12 items.
- Pathophysiology, clinical features and radiological findings of differentiation syndrome/all-trans-retinoic acid syndrome (Q27012691) (← links)
- Management of acute promyelocytic leukemia (Q34774164) (← links)
- Acute promyelocytic leukemia: an experience on 95 greek patients treated in the all-trans-retinoic Acid era (Q35640734) (← links)
- The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature (Q35640755) (← links)
- Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia (Q35717816) (← links)
- Emerging new approaches for the treatment of acute promyelocytic leukemia (Q36612619) (← links)
- Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2013 (Q37628630) (← links)
- Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives (Q37712353) (← links)
- Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia (Q40961287) (← links)
- Retinoic acid syndrome. Recognition, prevention and management (Q41753205) (← links)
- Differentiation syndrome in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene (Q46818452) (← links)
- Autophagy: New Insights into Mechanisms of Action and Resistance of Treatment in Acute Promyelocytic leukemia (Q92081865) (← links)